Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: Early- vs late-onset form

Archives of Neurology

Volumn 59, Issue 11, 2002, Pages 1771-1776

  Koike, Haruki ^a,b,c,d,e,f   Misu, Ken Ichiro ^a,b,c,d,e,f   Ikeda, Shu Ichi ^a,b,c,d,e,f   Ando, Yukio ^a,b,c,d,e,f   Nakazato, Masamitsu ^a,b,c,d,e,f   Ando, Eiko ^a,b,c,d,e,f   Yamamoto, Masahiko ^a,b,c,d,e,f   Hattori, Naoki ^a,b,c,d,e,f   Sobue, Gen ^a,b,c,d,e,f  

^a Study Group for Hereditary Neuropathy in Japan   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF MIYAZAKI   (Japan)

^f Nishinihon Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYLOID NEUROPATHY; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; ENDEMIC DISEASE; FAMILIAL DISEASE; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; AGED; AMINO ACID SUBSTITUTION; AMYLOID NEUROPATHIES, FAMILIAL; FEMALE; HEALTH SURVEYS; HUMANS; JAPAN; MALE; METHIONINE; MIDDLE AGED; PREALBUMIN; SEX FACTORS;

EID: 0036846492     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.11.1771     Document Type: Article

References (31)

1. Andrade C. A peculiar form of peripheral neuropathy: familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain. 1952;75:408-427.
2. Araki S, Mawatari S, Ohta M, Nakajima A, Kuroiwa Y. Polyneuritic amyloidosis in a Japanese family. Arch Neurol. 1968;18:593-602.
3. Andersson R. Familial amyloidosis with polyneuropathy: A clinical study based on patients living in northern Sweden. Acta Med Scand Suppl 1976;590:1-64.
4. Benson MD, Cohen AS. Generalized amyloid in a family of Swedish origin: A study of 426 family members in seven generations of a new kinship with neuropathy, nephropathy, and central nervous system involvement. Ann Intern Med. 1977;86:419-424.
5. Coutinho P, DeSilva AM, Lima JL, Barbosa AR. Forty years of experience with type I amyloid neuropathy: Review of 483 cases. In: Glenner GG, Costa PP, Freitas F, eds. AmyloidandAmyloidosis. Amsterdam, the Netherlands: Exerpta Medica; 1980:88-98.
6. Kito S, Itoga E, Kamiya K, Kishida T, Yamamura Y. Studies on familial amyloid polyneuropathy in Ogawa Village, Japan. Eur Neurol 1980;19:141-151.
7. Ikeda S, Hanyu N, Hongo M, et al. Hereditary generalized amyloidosis with polyneuropathy: Clinicopathological study of 65 Japanese patients. Brain. 1987;110:315-337.
8. Sobue G, Nakao N, Murakami K, et al. Type I familial amyloid polyneuropathy: A pathological study of the peripheral nervous system. Brain 1990;113:903-919.
9. Ando Y, Araki S, Shimoda O, Kano T. Role of autonomic nerve functions in patients with familial amyloidotic polyneuropathy as analyzed by laser Doppler flowmetry, capsule hydrograph, and cardiographic R-R interval. Muscle Nerve. 1992;15:507-512.
10. Nakazato M, Shiomi K, Miyazato M, Matsukura S. Type 1 familial amyloidotic polyneuropathy in Japan. Intern Med. 1992;31:1335-1338.
11. Drugge U, Andersson R, Chizari F, et al. Familial amyloidotic polyneuropathy in Sweden: A pedigree analysis. J Med Genet. 1993;30:388-392.
12. Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: Geographical distribution, age of onset, and prevalence. Hum Hered. 1993;43:288-294.
13. Reilly MM, Adams D, Booth DR, et al. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain. 1995;118:849-856.
14. Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet. 1995;60:515-521.
15. Misu K, Hattori N, Nagamatsu M, et al. Late-onset familial amyloid polyneuropathy type I (transthyretin Met 30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan: Clinicopathological and genetic features. Brain. 1999;122:1951-1962.
16. Sequeiros J, Sousa A, Coelho T. Sex differences and age-dependent penetrance in FAP type I. In: Natvig JB, Forre O, Husby G, et al, eds. Amyloid and Amyloidosis 1990. Dordrecht, the Netherlands: Kluwer Academic; 1991:687-690.
17. Saravia MJ, Costa PP, Goodman DS. Genetic expression of a transthyretin mutation in typical and late-onset Portuguese families with familial amyloidotic polyneuropathy. Neurology. 1986;36:1413-1417.
18. Sasaki Y, Yoshioka K, Tanahashi H, Furuya H, Sasaki H. Human transthyretin (prealbumin) gene and molecular genetics of familial amyloidotic polyneuropathy. Mol Biol Med. 1989;6:161-168.
19. Misu K, Hattori N, Ando Y, Ikeda S, Sobue G. Anticipation in early- but not late-onset familial amyloid polyenuropathy (TTR Met 30) in Japan. Neurology. 2000;55:451-452.
20. Ando Y, Ueyama H, Watanabe S, et al. Early involvement of motor nerve dysfunction in atypical cases with familial amyloidotic polyneuropathy (FAP) type I. Muscle Nerve. 1993;16:978-979.
21. Nakazato M, Tanaka M, Yamamura Y, et al. Abnormal transthyretin in asymptomatic relatives in familial amyloidotic polyneuropathy. Arch Neurol. 1987;44:1275-1278.
22. Yoshinaga T, Nakazato M, Ikeda S, Ohnishi A. Homozygosity for the transthyretin Met30 gene in three Japanese siblings with type I familial amyloidotic polyneuropathy. Neurology. 1992;42:2045-2047.
23. Ikeda S, Nakano T, Yanagisawa N, Nakazato M, Tsukagashi H. Asymptomatic homozygous gene carrier in a family with type I familial amyloid polyneuriopathy. Eur Neurol. 1992;32:308-313.
24. Holmgen G, Ando Y, Wikström L. Discordant symptoms in monozygotic twins with familial amyloidotic polyneuropathy (FAP) (TTR met30) amyloid. Int J Exp Clin Invest. 1997;4:178-180.
25. Yi S, Takahashi K, Naito M, et al. Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Am J Pathol. 1991;138:403-412.
26. Takaoka Y, Tashiro F, Yi S, et al. Comparison of amyloid deposition in two lines of transgenic mouse that model familial amyloidotic polyneuropathy, type I. Transgenic Res. 1997;6:261-269.
27. Coelho T, Sousa A, Lourenco E, Ramalheira J. A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected. J Med Genet. 1994;31:293-299.
28. Kincaid JC, Wallance MR, Benson MD. Late-onset familial amyloid polyneuropathy in an American family of English origin. Neurology. 1989;39:861-863.
29. Tashima K, Ando Y, Tanaka Y, Uchino M, Ando M. Change in age of onset in patients with familial amyloidotic polyneuropathy type 1. Intern Med. 1995;34:748-750.
30. Yamamoto K, Ikeda S, Hanyu N, Takeda S, Yanagisawa N. A pedigree analysis with minimized ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy. J Med Genet. 1998;35:23-30.
31. Sousa A, Coelho T, Lobato L, Sequeiros J. Anticipation of age at onset in familial amyloidotic polyneuropathy (Portuguese type). In: Natvig JB,Forre O, Husby G, et al, eds. Amyloid and Amyloidosis 1990. Dordrecht, the Netherlands: Kluwer Academic; 1991:694-697.